TCM Biotech International Corp. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 372.96 million compared to TWD 354.64 million a year ago.

Net income was TWD 13.27 million compared to TWD 6.91 million a year ago. Basic earnings per share from continuing operations was TWD 0.2717 compared to TWD 0.1455 a year ago. Diluted earnings per share from continuing operations was TWD 0.2717 compared to TWD 0.1455 a year ago.